Invenra

About:

Invenra operates as a biotechnology company focused on early stage drug discovery.

Website: http://invenra.com

Twitter/X: invenra

Top Investors: Venture Investors, Wisconsin Investment Partners, Venture Management, Madison Development Corporation, Rose Ventures

Description:

Invenra is focused on discovering the next generation of best-in-class biologics, with an emphasis on antibodies and their derivatives. The company's proprietary technology combines the cell-free expression of full-length antibodies and extreme miniaturization, enabling the screening of unprecedented numbers of full-length antibodies in phenotypic assays. ​ Invenra touts a broad scientific foundation and a team of scientists with deep expertise in key areas ranging from genomics to biochemistry to bioengineering. Their background is well balanced between cutting edge basic research and commercial products and services. The company was established in 2011 and is based in Madison, Wisconsin, United States.

Total Funding Amount:

$25.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)invenra.com

Founders:

Emile F. Nuwaysir, Roland Green

Number of Employees:

11-50

Last Funding Date:

2018-10-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai